Maravai Lifesciences Holdings (MRVI) Interest Expenses (2020 - 2026)

Maravai Lifesciences Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 76.48% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $37.6 million (up 43.78% YoY), while the FY2025 annual figure was $34.5 million, down 95.03% from the prior year.
• Interest Expenses for Q1 2026 stood at $6.1 million, down from $8.2 million in the prior quarter.
• The five-year high for Interest Expenses was $26.2 million in Q3 2025, with the low at $6.1 million in Q1 2026.
• The 5-year median for Interest Expenses is $24.4 million (2022), against an average of $19.3 million.
• The sharpest annual moves came in 2025 and 2026: Interest Expenses jumped 119.59% in 2025, then sank 76.48% in 2026.
• Maravai Lifesciences Holdings' Interest Expenses stood at $8.8 million in 2022, then surged by 56.73% to $13.8 million in 2023, then declined by 18.17% to $11.3 million in 2024, then decreased by 27.01% to $8.2 million in 2025, then decreased by 25.24% to $6.1 million in 2026.
• Business Quant data shows MRVI's Interest Expenses at $6.1 million in Q1 2026, $8.2 million in Q4 2025, and $26.2 million in Q3 2025.